Kestra Medical (KMTS) CFO Mahboob Vaseem Sells Shares

What Happened
Mahboob Vaseem, Chief Financial Officer of Kestra Medical Technologies, sold a total of 26,287 shares in open-market/private sales on August 7, 2026. The filings report two disposals: 25,787 shares at a weighted-average price of $25.87 (proceeds $667,218) and 500 shares at a weighted-average price of $26.33 (proceeds $13,165), for aggregate proceeds of approximately $680,383. These were sales (not purchases) and the filing notes they occurred pursuant to a Rule 10b5-1 trading plan adopted November 6, 2025.

Key Details

• Transaction date: 2026-08-07 (filed with the SEC on 2026-08-11).
• Trade details:
  • 25,787 shares sold @ weighted avg $25.87 — proceeds $667,218. Price range for these sales: $25.3100 to $26.3050 (per footnote).
  • 500 shares sold @ weighted avg $26.33 — proceeds $13,165. Price range for these sales: $26.3150 to $26.3600 (per footnote).
• Total shares sold: 26,287; total proceeds ≈ $680,383.
• Shares owned after the transaction: not specified in the information provided (check the full Form 4 for post-transaction holdings).
• Footnotes: F1 — trades executed under a Rule 10b5-1 plan (adopted 11/06/2025). F2/F3 — reported prices are weighted averages; detailed per-price breakdown available on request.
• Filing timeliness: The Form 4 was filed 4 days after the transaction; Form 4s are generally due within two business days, so this filing appears to have been submitted later than typical.

Context
Sales made under a pre-established Rule 10b5-1 plan are often routine and do not necessarily reflect the insider’s view of the company’s prospects. For retail investors, purchases generally carry clearer bullish signals than sales; when insiders sell, consider volume, pattern of past trades, and the presence of a 10b5-1 plan before drawing conclusions.